iProcess Global Research Inc

iProcess Global Research Inc. is a global provider of human biospecimens and clinical trial management services, established in 2004. The company operates a network of over 1,500 pre-qualified clinical collection sites across more than 30 countries, spanning five continents. Their infrastructure supports the sourcing of both banked and prospectively collected human biological materials, including tissues, blood, and various other samples. The company utilizes standardized collection protocols, AI-assisted laboratory workflows, and validated cold chain logistics to ensure sample integrity, regulatory compliance, and data quality for research programs. Their operations align with international standards such as ISO 20387 and CAP/CLIA, facilitating research across diverse cohorts and disease areas.

By providing seamless access to high-quality biospecimens and laboratory services, iProcess supports pharmaceutical, biotechnology, diagnostic, and life science organizations in advancing their research and development projects. The company addresses the complexities of global clinical trial management by navigating international regulations and hospital systems, helping clients accelerate their studies from early-stage research to large-scale clinical trials. With over two decades of experience, iProcess has served a wide range of clients, including private companies, government programs, and research institutions, contributing to pivotal trials and medical innovation. Their centralized approach aims to reduce variability in large-scale research and provide researchers with the precise biological materials required for critical studies.